“Marik filed his lawsuit against Sentara Healthcare on Nov. 9, arguing the organization is endangering the lives of its COVID patients by preventing him from using his treatment protocol, which he says has reduced mortality rates in the ICU from approximately between 40% and 60% to less than 20%…
In his motion, Marik said patients are dying ‘unnecessarily and unlawfully’ because Sentara Healthcare is ‘preventing terminally ill COVID patients from exercising their right to choose and to receive safe, potentially life-saving treatment determined to be appropriate for them by their attending physician.’
In an interview with The Defender, Marik said the hospital is prohibiting the use of a COVID protocol called “Math +”…
Instead, according to the lawsuit, Sentara recommends doctors use ‘toxic drugs’ like Remdesivir — an expensive medication associated with severe side effects — because the hospital receives a bonus each time doctors prescribe it.
In a press release, Marik said: ‘This case is about doctors having the ability to honor their Hippocratic Oath, to follow evidence-based medicine, and to treat our patients the best we know how. Corporations and faceless bureaucrats should not be allowed to interfere with doctor-patient decisions, especially when it can result in harm or death.’
Marik, a highly published physician with 35 years of experience, said Sentara also tried to criticize his character, even though they appointed him as the director of ICU.
Marik said he could no longer stand by while patients died unnecessarily without proper treatment, so he had no choice but to file a lawsuit allowing him and his colleagues to administer a combination of FDA-approved drugs and other therapies that have saved thousands of critically ill COVID patients in the last 18 months.”
Paul E. Marik v. Sentara Healthcare, memorandum of law in support of plaintiff’s motion for temporary injunction:
https://covid19criticalcare.com/wp-content/uploads/2021/11/Dr.-P.-Marik-v.-Sentara-Healthcare.pdf
2016 - 2023 Children's Health Defense® • All Rights Reserved